| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |